Quantum BioPharma (QNTM, Financial) has announced a new collaboration with BitGo Trust Company for securely managing its cryptocurrency assets, including Bitcoin, Solana, XRP, and DOGE. BitGo is recognized for its reliable and compliant custody solutions tailored for institutional needs, and it will provide Quantum BioPharma with top-tier security infrastructure for safeguarding its crypto holdings. The company's CEO and Executive Co-Chairman, Zeeshan Saeed, expressed their commitment to maintaining high security and compliance standards through this partnership. As Quantum BioPharma deepens its involvement in cryptocurrency, BitGo's expertise will be instrumental in ensuring the secure custody of these digital assets.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Quantum BioPharma Ltd (QNTM, Financial) is $169.00 with a high estimate of $169.00 and a low estimate of $169.00. The average target implies an upside of 1,383.76% from the current price of $11.39. More detailed estimate data can be found on the Quantum BioPharma Ltd (QNTM) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Quantum BioPharma Ltd's (QNTM, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
